Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,700,088 | 230,064 | 1,241,201 | 1,701,954 | 2,461,419 |
| Depreciation Amortization | 20,499 | 27,026 | 43,158 | 34,773 | 36,714 |
| Accounts receivable | 1,067 | 31,712 | -29,143 | -400 | 159,861 |
| Other Working Capital | 1,009,038 | 414,802 | 234,449 | 202,962 | 260,584 |
| Other Operating Activity | 257,110 | 1,440,376 | 527,871 | 95,340 | -1,251,339 |
| Operating Cash Flow | $2,987,802 | $2,143,980 | $2,017,536 | $2,034,629 | $1,667,239 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,115,522 | -1,741,640 | -2,191,502 | N/A | N/A |
| PPE Investments | N/A | -21,215 | N/A | -2,182,246 | -1,721,291 |
| Purchase Of Investment | -24,942 | -812,109 | -1,455,609 | -1,795,438 | -1,307,404 |
| Sale Of Investment | 69,713 | 1,545,543 | 1,776,831 | 1,203,280 | 875,070 |
| Other Investing Activity | -2,038 | 0 | 0 | 15,084 | 0 |
| Investing Cash Flow | $-2,072,789 | $-1,029,421 | $-1,870,280 | $-2,759,320 | $-2,153,625 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 350,000 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 1,272,533 | 11,891,030 | N/A |
| Debt Repayment | -1,000,000 | N/A | N/A | -11,210,400 | -294,000 |
| Common Stock Issued | 7,476 | 7,192 | 44,213 | 1,976,183 | N/A |
| Common Stock Repurchased | -304,759 | N/A | N/A | N/A | -4,266 |
| Dividend Paid | -854,848 | -950,701 | -918,588 | -1,122,930 | -893,360 |
| Other Financing Activity | -346,623 | -1,347 | -13,046 | -46,711 | 0 |
| Financing Cash Flow | $-2,148,754 | $-944,856 | $385,112 | $1,487,172 | $-1,191,626 |
| Beginning Cash Position | 1,710,751 | 1,541,048 | 1,008,680 | 246,199 | 1,924,211 |
| End Cash Position | 477,010 | 1,710,751 | 1,541,048 | 1,008,680 | 246,199 |
| Net Cash Flow | $-1,233,741 | $169,703 | $532,368 | $762,481 | $-1,678,012 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,987,802 | 2,143,980 | 2,017,536 | 2,034,629 | 1,667,239 |
| Capital Expenditure | N/A | -21,215 | N/A | -2,182,246 | -1,721,291 |
| Free Cash Flow | 2,987,802 | 2,122,765 | 2,017,536 | -147,617 | -54,052 |